Navigation Links
NuVasive to Host Investor Reception on September 11, 2007
Date:9/7/2007

Surgery

at Albert Einstein College of Medicine, New York, NY

* Faheem Sandhu, MD, Assistant Professor, Department of Neurosurgery and

Director of Complex and Minimally Invasive Spinal Surgery at Georgetown

University Hospital, Washington, DC.

A live Web cast of the investor reception presentations will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, http://www.nuvasive.com, for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical internal fixation products and its R&D pipeline emphasizes both MAS and motion preservation.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-l
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Venture Investors early-stage fund grows to $115 million
2. Investor warns of angel-venture funding gap
3. Brazilian bio-industry should impress American investors
4. Investors raise $25 million for biodiesel plant
5. Bio-energy and cleantech grab attention of investors
6. Venture Investors to open Michigan office
7. Early-stage executives hear from investors
8. Commerce qualifies seven for investor tax credits
9. Investor links East Coast funds to Midwest tech
10. Angel investors commit $12.7B in first half of `06
11. Wisconsin investors the lifeblood of New Jersey biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine”) (TSX: ... today announced that the U.S. Food and Drug ... designation and Phase I clinical trials of the ... mutual co-development agreement signed with Gilead Life Sciences. ... for the DPX-Survivac. , “We have been in ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... 27, 2015 FamilyFarms Group is pleased ... of State Line Farms, received the 2015 Tomorrow’s Top ... under the age of 35, who has demonstrated excellence ... honor to win the Tomorrow's Top Producer Horizon Award. ... the Top Producer Award and learning from their experiences. ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... , , , , , , For fast and efficient multiplex ... , , , ... Storage and Stability , Technical Assistance ... Product Use Limitations , Product Warranty and Satisfaction Guarantee , ...
... , , , Fully automated sample preparation for clinical , ... , , ... for reliable results , , QIAsoft MDx ... Full process documentation and sample tracking for effortless data management , ...
... , , , The BioRobot MDx is the latest addition , ... of scientists requiring standardized protocols in environments such as clinical , ... , , ... , Standardized nucleic acid purification and reaction setup ...
Cached Biology Technology:QIAGEN Multiplex PCR Handbook 2QIAGEN Multiplex PCR Handbook 3QIAGEN Multiplex PCR Handbook 4QIAGEN Multiplex PCR Handbook 5QIAGEN Multiplex PCR Handbook 6QIAGEN Multiplex PCR Handbook 7QIAGEN Multiplex PCR Handbook 8QIAGEN Multiplex PCR Handbook 9QIAGEN Multiplex PCR Handbook 10QIAGEN Multiplex PCR Handbook 11QIAGEN Multiplex PCR Handbook 12QIAGEN Multiplex PCR Handbook 13QIAGEN Multiplex PCR Handbook 14QIAGEN Multiplex PCR Handbook 15QIAGEN Multiplex PCR Handbook 16QIAGEN Multiplex PCR Handbook 17QIAGEN Multiplex PCR Handbook 18QIAGEN Multiplex PCR Handbook 19QIAGEN Multiplex PCR Handbook 20QIAGEN Multiplex PCR Handbook 21QIAGEN Multiplex PCR Handbook 22QIAGEN Multiplex PCR Handbook 23QIAGEN Multiplex PCR Handbook 24QIAGEN Multiplex PCR Handbook 25QIAGEN Multiplex PCR Handbook 26QIAGEN Multiplex PCR Handbook 27QIAGEN Multiplex PCR Handbook 28QIAGEN Multiplex PCR Handbook 29QIAGEN Multiplex PCR Handbook 30QIAGEN Multiplex PCR Handbook 31QIAGEN Multiplex PCR Handbook 32QIAGEN Multiplex PCR Handbook 33BioRobot MDx Workstation 2BioRobot MDx standardize your automated protocols in clinical , laboratories 2BioRobot MDx standardize your automated protocols in clinical , laboratories 3
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source ... launch of its new website design. "When we ... infancy", says Peter O,Neill , founder and CEO of ... industry needs involvement from the key players on a very ...
(Date:1/22/2015)... Jan. 15, 2015  BellBrook Labs, a leader in ... the launch of a TR-FRET (time resolved Forster ... UDP Assay, a high throughput screening assay for ... will allow for sensitive detection of hundreds of ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Researchers in a multicenter international study have identified a new ... breast cancer by more than a third. Further, ... well-known breast cancer gene BRCA1. Alternations in either gene cause ... a path to breast cancer developing. This leads researchers to ...
... PHILADELPHIA - James Shorter, PhD, Assistant Professor of Biochemistry ... Medicine, has been named an inaugural recipient of the ... award totals $1.5 million in direct costs over five ... are in the early stages of their careers. More ...
... University of California, Irvine scientists have discovered how to ... most common form of mental impairment. Neurobiologist Julie ... linked to fragile X syndrome blocks brain cells from ... called fragile X mental retardation 1 (Fmr1) -- is ...
Cached Biology News:Researchers find new gene linked to breast cancer 2Researchers find new gene linked to breast cancer 3Penn biochemist receives NIH New Innovator's Award 2UCI researchers restore memory process in most common form of mental disability 2
... NAP-10 Columns, 50. For rapid and efficient ... in less than 15 minutes by gravity ... distilled water containing 0.15% Kathon CG/ICP Biocide.Available ... 0.5 ml (NAP-5), 1 ml (NAP-10) ...
Human ROR1 Affinity Purified Polyclonal Ab...
Human Rad1 MAb (Clone 33)...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Biology Products: